Cornwall & Isles of Scilly Community Prescribing and Dispensing News: 2015

Month

Topics

No. 270
December 2015
 Pdf1


  • MHRA Drug Safety Update (November 2015)
  • Nicorandil
  • CAPC Technical Working Group
    - Aripiprazole depot injection
    - Ulipristal (EllaOne)
    - Jaydess
  • NICE Guidance
    - NICE NG 23 (November 2015): The menopause: Diagnosis and management
    - NICE TA 367 (November 2015): Vortioxetine for treating major depressive episodes
    - NICE NG28 (December 2015): Type 2 diabetes in adults: Management
  • AF decision support
  • Openprescribing - Prescribing data publicly and easily accessible!
  • Antibiotic prescribing 

No. 269 
October 2015
 Pdf1


  • MHRA Drug Safety Update (September/October 2015)
  • NICE Guidance
    - NICE NG 20 (September 2015): Coeliac Disease: Recognition, Assessment and Management 
    - NICE TA 355 (September 2015): Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
  • Shared decision making
  • Dental patients taking anticoagulants and antiplatelets
  • Winterbourne medicines programme
  • Buccal midazolam

No. 268 
August 2015
 Pdf1

  • MHRA Drug Safety Update (July 2015)
  • Ezetimibe
  • NICE Guidance
    - NICE TA 345 (July 2015): Naloxegol for treating opioid-induced constipation
    - NICE NG15 (August 2015): Antimicrobial stewardship
    - NICE NG17 (August 2015): Type 1 diabetes in adults
    - NICE NG18 (August 2015): Diabetes (type 1 and type 2) in children and young people
  • Antimicrobial resistance
  • Primary Care Antibiotic Guide
  • Asthma in adults - LAMA or high dose inhaled steroid

No. 267 
July 2015
 Pdf1


  • MHRA Drug Safety Update (June 2015)
  • NICE Guidance
    - NICE CG 97 (June 2015): Lower urinary tract symptoms in men: Assessment and management.
    - NICE NG8 (June 2015): Anaemia management in people with chronic kidney disease
    - NICE TA 341 (June 2015): Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
  • DOACS
  •  CAPC Technical Working Group
    - Fluticasone / salmeterol (Sirdupla) MDI
  • Budesonide / formoterol combination inhalers

No. 266 
May 2015 
Pdf1

  • MHRA Drug Safety Update (April 2015)
  • Oral ketoconazole
  • Co-enzyme Q10
  • CAPC Technical Working Group
    - Tiotropium (Spiriva Respimat)
    - Ultibro Breezhaler
    - Magnaspartate sachets
    - Levobupivacaine
  • Cognitive psychology

No. 265 
April 2015
 Pdf1

  • NICE Guidance
    - NICE TA 337: Rifaximin for preventing episodes of hepatic encephalopathy in people aged 18 tears and older
  • Insulin degludec
  • Bimatoprost eye drops
  • Quality tip of the month - Azathioprine and allopurinol interaction
  • High dose ibuprofen
  • Polypharmacy
  • European regulatory system for medicines

No. 264 
March 2015
 Pdf1

  • MHRA Drug Safety Update (March 2015)
  •  CAPC Technical Working Group
    - Simbrinza eye drops
    - Monoprost eye drops
    - Brimonidine (Mirvaso) gel
    - DuoResp Spiromax
  • NICE Guidance
    - Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
    - Empagliflozin in combination therapy for treating type 2 diabetes
    - Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes
    - Depression in children and young people
  • Alprostadil cream (vitaros) – Not in the formulary
  • BNF 69 March 2015 - Update

No. 263 
February 2015
 Pdf1

  • MHRA Drug Safety Update (January 2015)
  • Hydroxyzine
  • NICE Guidance
    - NICE NG1: Gastro-oesophageal reflux disease 
  •  Clinical Decision Making
  •  Low molecular weight heparins - Safety alert
  •  E-learning - Prescribing in General Practice

No. 262 
January 2015
 Pdf1

  • MHRA Drug Safety Update (December 2014)
  • Potassium permanganate and accidental ingestion
  • Deprescribing
  • NICE Guidance 
    - NICE CG 191: Pneumonia
    - NICE TA 327: Dabigatran: deep vein thrombosis and/or
      pulmonary embolism
  • Asthma and effect of inhaled steroids on growth
  • Opioids in renal impairment
  • Pregabalin & gabapentin – advice on the risk of misuse